Rifasutenizol
Antibiotic medication
Rifasutenizol | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Rifasutenizol is a broad-spectrum antibiotic used primarily in the treatment of bacterial infections. It belongs to the class of antibiotics known as rifamycins, which are known for their effectiveness against Mycobacterium tuberculosis and other mycobacteria.
Mechanism of Action[edit | edit source]
Rifasutenizol works by inhibiting bacterial RNA polymerase, an enzyme critical for the transcription of DNA into RNA. This inhibition prevents the bacteria from synthesizing essential proteins, ultimately leading to their death. The drug binds to the beta subunit of the RNA polymerase, which is a mechanism similar to other rifamycins.
Pharmacokinetics[edit | edit source]
Rifasutenizol is well absorbed when administered orally, with peak plasma concentrations occurring approximately 2 hours after ingestion. It is widely distributed throughout the body, including the central nervous system, which makes it effective in treating meningitis caused by susceptible organisms. The drug is metabolized in the liver and excreted primarily in the bile.
Clinical Uses[edit | edit source]
Rifasutenizol is indicated for the treatment of various bacterial infections, including:
It is often used in combination with other antibiotics to prevent the development of antibiotic resistance.
Side Effects[edit | edit source]
Common side effects of rifasutenizol include:
Serious side effects may include hepatotoxicity, hypersensitivity reactions, and hematological disorders. Patients are advised to monitor liver function regularly during treatment.
Drug Interactions[edit | edit source]
Rifasutenizol can interact with several other medications, including:
These interactions may reduce the effectiveness of the co-administered drugs or increase the risk of adverse effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD